Last reviewed · How we verify

NCT01444053

Retrospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses

Completed Last updated 20 June 2017
What this trial tests

trial testing No Intervention in Refractive Errors in 41 participants. Completed in 1 December 2011.

Timeline
1 June 2011
Primary endpoint
1 December 2011
1 December 2011

Quick facts

Lead sponsorJohnson & Johnson Vision Care, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment41
Start date1 June 2011
Primary completion1 December 2011
Estimated completion1 December 2011
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Johnson & Johnson Vision Care, Inc. — full company profile →

Who can join

Adults 18 to 43, any sex, with Refractive Errors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the long term effect of ultra-violet filtering contact lenses on macular pigment density (MPOD) and accommodative function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No Intervention

Trials testing the same drug.

Other recruiting trials for Refractive Errors

Currently open trials in the same condition.

Other Johnson & Johnson Vision Care, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01444053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing